BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

281 related articles for article (PubMed ID: 12918062)

  • 41. Induction of apoptosis in human stomach cancer cells by green tea catechins.
    Hibasami H; Komiya T; Achiwa Y; Ohnishi K; Kojima T; Nakanishi K; Akashi K; Hara Y
    Oncol Rep; 1998; 5(2):527-9. PubMed ID: 9468594
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Inhibition of gap junctional intercellular communication by the green tea polyphenol (-)-epigallocatechin gallate in normal rat liver epithelial cells.
    Kang NJ; Lee KM; Kim JH; Lee BK; Kwon JY; Lee KW; Lee HJ
    J Agric Food Chem; 2008 Nov; 56(21):10422-7. PubMed ID: 18828601
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Synthetic analogs of green tea polyphenols as proteasome inhibitors.
    Smith DM; Wang Z; Kazi A; Li LH; Chan TH; Dou QP
    Mol Med; 2002 Jul; 8(7):382-92. PubMed ID: 12393936
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Anticancer effects of (-)-epigallocatechin-3-gallate on ovarian carcinoma cell lines.
    Huh SW; Bae SM; Kim YW; Lee JM; Namkoong SE; Lee IP; Kim SH; Kim CK; Ahn WS
    Gynecol Oncol; 2004 Sep; 94(3):760-8. PubMed ID: 15350370
    [TBL] [Abstract][Full Text] [Related]  

  • 45. (-)-Epigallocatechin gallate induced apoptosis in human adrenal cancer NCI-H295 cells through caspase-dependent and caspase-independent pathway.
    Wu PP; Kuo SC; Huang WW; Yang JS; Lai KC; Chen HJ; Lin KL; Chiu YJ; Huang LJ; Chung JG
    Anticancer Res; 2009 Apr; 29(4):1435-42. PubMed ID: 19414399
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Epigallocatechin gallate dose-dependently induces apoptosis or necrosis in human MCF-7 cells.
    Hsuuw YD; Chan WH
    Ann N Y Acad Sci; 2007 Jan; 1095():428-40. PubMed ID: 17404055
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Synthetic peracetate tea polyphenols as potent proteasome inhibitors and apoptosis inducers in human cancer cells.
    Kuhn D; Lam WH; Kazi A; Daniel KG; Song S; Chow LM; Chan TH; Dou QP
    Front Biosci; 2005 May; 10():1010-23. PubMed ID: 15769601
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Treatment of epigallocatechin-3-gallate inhibits matrix metalloproteinases-2 and -9 via inhibition of activation of mitogen-activated protein kinases, c-jun and NF-kappaB in human prostate carcinoma DU-145 cells.
    Vayalil PK; Katiyar SK
    Prostate; 2004 Apr; 59(1):33-42. PubMed ID: 14991864
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Specific killing of multiple myeloma cells by (-)-epigallocatechin-3-gallate extracted from green tea: biologic activity and therapeutic implications.
    Shammas MA; Neri P; Koley H; Batchu RB; Bertheau RC; Munshi V; Prabhala R; Fulciniti M; Tai YT; Treon SP; Goyal RK; Anderson KC; Munshi NC
    Blood; 2006 Oct; 108(8):2804-10. PubMed ID: 16809610
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Study of the combined effect of X-irradiation and epigallocatechin-gallate (a tea component) on the growth inhibition and induction of apoptosis in human cancer cell lines.
    Baatout S; Jacquet P; Derradji H; Ooms D; Michaux A; Mergeay M
    Oncol Rep; 2004 Jul; 12(1):159-67. PubMed ID: 15201978
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Synergistic effects of (--)-epigallocatechin gallate with (--)-epicatechin, sulindac, or tamoxifen on cancer-preventive activity in the human lung cancer cell line PC-9.
    Suganuma M; Okabe S; Kai Y; Sueoka N; Sueoka E; Fujiki H
    Cancer Res; 1999 Jan; 59(1):44-7. PubMed ID: 9892181
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Structure-activity relationships of synthetic analogs of (-)-epigallocatechin-3-gallate as proteasome inhibitors.
    Kazi A; Wang Z; Kumar N; Falsetti SC; Chan TH; Dou QP
    Anticancer Res; 2004; 24(2B):943-54. PubMed ID: 15161048
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Essential role of caspases in epigallocatechin-3-gallate-mediated inhibition of nuclear factor kappa B and induction of apoptosis.
    Gupta S; Hastak K; Afaq F; Ahmad N; Mukhtar H
    Oncogene; 2004 Apr; 23(14):2507-22. PubMed ID: 14676829
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Mechanisms of inhibition of tumor angiogenesis and vascular tumor growth by epigallocatechin-3-gallate.
    Fassina G; Venè R; Morini M; Minghelli S; Benelli R; Noonan DM; Albini A
    Clin Cancer Res; 2004 Jul; 10(14):4865-73. PubMed ID: 15269163
    [TBL] [Abstract][Full Text] [Related]  

  • 55. (-)-Epigallocatechin gallate induces Fas/CD95-mediated apoptosis through inhibiting constitutive and IL-6-induced JAK/STAT3 signaling in head and neck squamous cell carcinoma cells.
    Lin HY; Hou SC; Chen SC; Kao MC; Yu CC; Funayama S; Ho CT; Way TD
    J Agric Food Chem; 2012 Mar; 60(10):2480-9. PubMed ID: 22313388
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Epigallocatechin-3-Gallate suppresses early stage, but not late stage prostate cancer in TRAMP mice: mechanisms of action.
    Harper CE; Patel BB; Wang J; Eltoum IA; Lamartiniere CA
    Prostate; 2007 Oct; 67(14):1576-89. PubMed ID: 17705241
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Synergistic effect of green tea catechins on cell growth and apoptosis induction in gastric carcinoma cells.
    Horie N; Hirabayashi N; Takahashi Y; Miyauchi Y; Taguchi H; Takeishi K
    Biol Pharm Bull; 2005 Apr; 28(4):574-9. PubMed ID: 15802789
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Chemopreventive effects of tea extracts and various components on human pancreatic and prostate tumor cells in vitro.
    Lyn-Cook BD; Rogers T; Yan Y; Blann EB; Kadlubar FF; Hammons GJ
    Nutr Cancer; 1999; 35(1):80-6. PubMed ID: 10624710
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Inhibition of growth and induction of apoptosis in human cancer cell lines by tea polyphenols.
    Yang GY; Liao J; Kim K; Yurkow EJ; Yang CS
    Carcinogenesis; 1998 Apr; 19(4):611-6. PubMed ID: 9600345
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Green tea epigallocatechin gallate shows a pronounced growth inhibitory effect on cancerous cells but not on their normal counterparts.
    Chen ZP; Schell JB; Ho CT; Chen KY
    Cancer Lett; 1998 Jul; 129(2):173-9. PubMed ID: 9719459
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.